5TT-27208-77603
4 vaccinations
6 coded responses
43 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 210 / MD
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Registered in v-safe
-
2021-03-04
Dose 1 — Pfizer-BioNTech
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-18
-
2021-03-25
Dose 2 — Pfizer-BioNTech
- 2021-03-25
- 2021-03-26
- 2021-03-27
-
2021-03-28
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal discomfort, Pain in extremity — Feeling: Fair · HeadacheFree text: arm soreness, tickle in throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
-
2021-04-29
Survey response — day 35, dose 2MedDRA: Condition aggravated, Hypersensitivity, Pre-existing disease — Feeling: GoodFree text: worsened environmental allergiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-06
- 2021-06-24
- 2021-09-23
-
2021-10-12
Dose 3 — Pfizer-BioNTech
- 2021-11-17
- 2021-11-23
-
2022-01-11
Survey response — 3 months, dose 3MedDRA: Ectopic pregnancy, Office visit, Surgery — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: ectopic pregnancy · Healthcare visit (other): Outpatient surgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-01-11
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-12
-
2022-01-13
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-04-12
Survey response — 6 months, dose 3MedDRA: Adverse reaction — Feeling: FairFree text: More allergy symptoms earlier in the seasonMedDRA releases: 2024-11 · check-in free text available
-
2022-10-12
Survey response — 12 months, dose 3MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-10-12
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-13
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-13
-
2022-10-14
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-15
- 2022-10-16
- 2022-10-17
- 2022-10-18
- 2022-10-19
- 2022-10-20
- 2022-10-27
- 2022-11-03
- 2022-11-10
-
2022-11-17
Survey response — day 35, dose 4MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: congestion, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-11-24
- 2023-01-12
- 2023-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-25 | Pfizer-BioNTech | |
| 3 | 2021-10-12 | Pfizer-BioNTech | No |
| 4 | 2022-10-13 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-11 | Successful 2022-01-13 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-10-12 | Unsuccessful |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): arm soreness, tickle in throat
Release 8 — day 35, dose 2
Symptoms: worsened environmental allergies
Release 10 — 3 months, dose 3
Release 11 — 6 months, dose 3
Symptoms: More allergy symptoms earlier in the season
Release 12 — 12 months, dose 3
Symptoms: Pregnancy
Release 12 — day 35, dose 4
Symptoms: congestion, runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Surgery | · | · | ✓ |
| SD | Adverse reaction | · | · | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Ectopic pregnancy | · | · | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Oropharyngeal discomfort | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release